Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Nilotinib | 19.9526 | uM | 4 | 1250.00 | 665.42 | 2824.00 | 2022.25 | 1.3965 | 1.4630 |
| BT-20 | Nilotinib | 1 | uM | 4 | 1250.00 | 665.42 | 2387.00 | 2022.25 | 1.1804 | 1.2179 |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2337.00 | 2022.25 | 1.1556 | 1.1888 | |
| BT-20 | NVP-TAE684 | 1 | uM | 4 | 1250.00 | 665.42 | 1599.00 | 2022.25 | 0.7907 | 0.7276 |
| BT-20 | Nilotinib | 0.031623 | uM | 4 | 1250.00 | 665.42 | 2352.00 | 2022.25 | 1.1631 | 1.1975 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 2014.00 | 2022.25 | 0.9959 | 0.9949 |
| BT-20 | Etoposide | 3.1623 | uM | 4 | 1250.00 | 665.42 | 808.00 | 2022.25 | 0.3996 | 0.1287 |
| BT-20 | Etoposide | 0.31623 | uM | 4 | 1250.00 | 665.42 | 1621.00 | 2022.25 | 0.8016 | 0.7423 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 4 | 1250.00 | 665.42 | 2215.00 | 2022.25 | 1.0953 | 1.1168 |
| BT-20 | Etoposide | 0.1 | uM | 4 | 1250.00 | 665.42 | 2186.00 | 2022.25 | 1.0810 | 1.0995 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 4 | 1250.00 | 665.42 | 1769.00 | 2022.25 | 0.8748 | 0.8399 |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1829.00 | 2022.25 | 0.9044 | 0.8786 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1647.00 | 2022.25 | 0.8144 | 0.7597 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1503.00 | 2022.25 | 0.7432 | 0.6621 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1777.00 | 2022.25 | 0.8787 | 0.8451 | |
| BT-20 | PLX-4720 | 19.9526 | uM | 4 | 1250.00 | 665.42 | 1155.00 | 2022.25 | 0.5712 | 0.4104 |
| BT-20 | Nilotinib | 3.1623 | uM | 4 | 1250.00 | 665.42 | 2024.00 | 2022.25 | 1.0009 | 1.0011 |
| BT-20 | Etoposide | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 1989.00 | 2022.25 | 0.9836 | 0.9794 |
| BT-20 | Etoposide | 0.031623 | uM | 4 | 1250.00 | 665.42 | 2225.00 | 2022.25 | 1.1003 | 1.1228 |
| BT-20 | PLX-4720 | 0.031623 | uM | 4 | 1250.00 | 665.42 | 2377.00 | 2022.25 | 1.1754 | 1.2121 |
| BT-20 | Nilotinib | 0.31623 | uM | 4 | 1250.00 | 665.42 | 2290.00 | 2022.25 | 1.1324 | 1.1612 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 2391.00 | 2022.25 | 1.1823 | 1.2202 |
| BT-20 | PLX-4720 | 0.1 | uM | 4 | 1250.00 | 665.42 | 2448.00 | 2022.25 | 1.2105 | 1.2531 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 1250.00 | 665.42 | 2090.00 | 2022.25 | 1.0335 | 1.0415 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 4 | 1250.00 | 665.42 | 2499.00 | 2022.25 | 1.2358 | 1.2822 |